Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis

Zhichen Pu; Guang-Zhen Wu; QiFei Wang

doi:10.18632/oncotarget.15082

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis

Zhichen Pu, Guang-Zhen Wu _ and QiFei Wang

PDF | HTML | How to cite

Oncotarget. 2017; 8:19825-19833. https://doi.org/10.18632/oncotarget.15082

Metrics: PDF 1554 views | HTML 1825 views | ?

Abstract

Zhichen Pu1,2,*, Guang-Zhen Wu1,*, QiFei Wang1

1Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China

2State Key Laboratory of Natural Medicines, Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

*These authors have contributed equally to this work

Correspondence to:

QiFei Wang, email: [email protected]

Keywords: survivin, renal cell carcinoma, meta-analysis, prognosis

Received: August 19, 2016 Accepted: November 07, 2016 Published: February 04, 2017

ABSTRACT

Background: In recent years, survivin expression had been investigated as a prognostic biomarker for renal cell carcinoma (RCC), however, the results were conflicting. This study was aimed to explore the association between survivin expression and clinicalpathological features and the prognostic value for cancer-specific survival (CSS) and overall survival (OS) in RCC.

Results: Eleven studies with 1,697 subjects were included in this meta-analysis. The results showed that survivin expression was associated with higher tumor grade (OR=4.25, 95%CI: 3.04-5.95, p<0.001), advanced tumor stage (OR=3.83, 95%CI: 2.01-7.3, p<0.001) and lymph node metastasis (OR=4.19, 95%CI: 2.34-7.52, p<0.001), but had no association with age, gender or distant metastasis. In addition, survivin expression was also correlated with poor CSS (HR=2.08, 95%CI: 1.07-4.05, p=0.032) and poor OS (HR=2.28, 95%CI: 1.57-3.33, p<0.001).

Materials and Methods: Literature was searched by PubMed, Embase and Web of Science. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were extracted from eligible studies. Fixed or random effects model were used to calculate pooled HRs and 95%CIs according to heterogeneity.

Conclusions: This study demonstrated that survivin expression was associated with more aggressive clinical features and predicted poor CSS and OS in patients with RCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15082

Publication Alerts

Research Papers:

Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis

Abstract